Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.53% | -3.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.53% | -3.10% | |||
| Cost of Revenue | 10.42% | -14.51% | |||
| Gross Profit | -18.99% | 0.68% | |||
| SG&A Expenses | -6.35% | 4.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.20% | -5.45% | |||
| Operating Income | -60.24% | 24.65% | |||
| Income Before Tax | -21.62% | 11.46% | |||
| Income Tax Expenses | -72.90% | 317.57% | |||
| Earnings from Continuing Operations | -16.24% | 7.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.24% | 7.30% | |||
| EBIT | -60.24% | 24.65% | |||
| EBITDA | -107.43% | -103.86% | |||
| EPS Basic | -15.73% | 4.65% | |||
| Normalized Basic EPS | -21.13% | 8.95% | |||
| EPS Diluted | -15.73% | 4.65% | |||
| Normalized Diluted EPS | -21.13% | 8.95% | |||
| Average Basic Shares Outstanding | 0.41% | -2.76% | |||
| Average Diluted Shares Outstanding | 0.41% | -2.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||